PROF Revenue Breakdown
PROF Revenue Breakdown summary
Profound Medical Corp. (PROF). Quarter ended 2026-06-30 · 10-Q · every retained filed quarter remains available.
- 2025-12-31: Others Not split by product in the filing$16.10M100.00%; Total revenue $16.10M.
- 2024-12-31: Others Not split by product in the filing$9.74M100.00%; Total revenue $9.74M.
- 2023-12-31: Others Not split by product in the filing$5.90M100.00%; Total revenue $5.90M.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $16.10M 100.00% | $16.10M |
| 2024-12-31 | Not split by product in the filing $9.74M 100.00% | $9.74M |
| 2023-12-31 | Not split by product in the filing $5.90M 100.00% | $5.90M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $2.48M 100.00% | $2.48M |
| 2026-03-31 | Not split by product $5.34M 100.00% | $5.34M |
| 2025-12-31 | Not split by product $5.98M 100.00% | $5.98M |
| 2025-09-30 | Not split by product $5.06M 100.00% | $5.06M |
| 2025-06-30 | Not split by product $1.98M 100.00% | $1.98M |
| 2025-03-31 | Not split by product $2.34M 100.00% | $2.34M |
| 2024-12-31 | Not split by product $4.03M 100.00% | $4.03M |
| 2024-09-30 | Not split by product $2.54M 100.00% | $2.54M |
| 2024-06-30 | Not split by product $1.95M 100.00% | $1.95M |
| 2024-03-31 | Not split by product $1.22M 100.00% | $1.22M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |